The Role and Importance of Screening in Gastrointestinal Disease

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F12%3A12356" target="_blank" >RIV/00216208:11110/12:12356 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00064165:_____/12:12356

Výsledek na webu

<a href="http://efcclm.eu/file_download/221/FFESCC+,+EFLM+Postgraduate+Course+8+" target="_blank" >http://efcclm.eu/file_download/221/FFESCC+,+EFLM+Postgraduate+Course+8+</a>

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

The Role and Importance of Screening in Gastrointestinal Disease

Popis výsledku v původním jazyce

This paper is an overview, and summarizes all of the major recent advances in laboratory methods having been used for screening in gastroenterology, which have been published in the last several decades. In Europe, colorectal cancer is the second most frequent malignant disease, and now with quantitative immunochemical FOBT haemoglobin analysing of the stool we currently have the best screening test to date, with an accuracy of nearly 95%. Celiac disease affects ~1% of most populations, but remains largely unrecognized. The recommended methods for screening are currently by the detection of antibodies for IgG tTGA and IgG DGP. Evaluations of screening are now discussed in other gastroenterology diseases - such as chronic atrophic gastritis (CAG), and inflammatory bowel disease (IBD). Detection of infection by Helicobacter pylori and stomach-specific plasma biomarkers, especially pepsinogen I/II ratio, could help with the prevention of gastric carcinomas, as well. The use of faecal calp

Název v anglickém jazyce

The Role and Importance of Screening in Gastrointestinal Disease

Popis výsledku anglicky

This paper is an overview, and summarizes all of the major recent advances in laboratory methods having been used for screening in gastroenterology, which have been published in the last several decades. In Europe, colorectal cancer is the second most frequent malignant disease, and now with quantitative immunochemical FOBT haemoglobin analysing of the stool we currently have the best screening test to date, with an accuracy of nearly 95%. Celiac disease affects ~1% of most populations, but remains largely unrecognized. The recommended methods for screening are currently by the detection of antibodies for IgG tTGA and IgG DGP. Evaluations of screening are now discussed in other gastroenterology diseases - such as chronic atrophic gastritis (CAG), and inflammatory bowel disease (IBD). Detection of infection by Helicobacter pylori and stomach-specific plasma biomarkers, especially pepsinogen I/II ratio, could help with the prevention of gastric carcinomas, as well. The use of faecal calp

Druh

D - Stať ve sborníku

CEP obor

FB - Endokrinologie, diabetologie, metabolismus, výživa

OECD FORD obor

—

Projekt

—

Návaznosti

O - Projekt operacniho programu

Rok uplatnění

2012

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název statě ve sborníku

New Trends in Classification, Monitoring and Management of Gastrointestinal Disease

ISBN

978-953-176-593-0

ISSN

—

e-ISSN

—

Počet stran výsledku

7

Strana od-do

15-22

Název nakladatele

European Federation of Clinical Chemistry and Laboratory Medicine

Místo vydání

Dubrovník

Místo konání akce

Dubrovník

Datum konání akce

9. 11. 2012

Typ akce podle státní příslušnosti

EUR - Evropská akce

Kód UT WoS článku

—